Patents for A61P 23 - Anaesthetics (4,141)
07/2005
07/26/2005CA2285203C Compositions containing capsaicin or capsaicin analogues and a local anesthetic
07/21/2005US20050159452 Nociceptin analogs
07/20/2005EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
07/20/2005CN1640482A Pure Chinese medicine preparation for parodontium anaesthesia and its preparing process
07/20/2005CN1211085C Compositions having improved stability
07/19/2005US6919363 Central nervous system disorders; antiischemic agents; analgesics
07/14/2005WO2005009480A3 Implants containing codrugs
07/14/2005WO2004082585A3 Water-soluble conjugates of phenytoin
07/14/2005US20050154047 Exert the beneficial effects of melatonin including anti-oxidation, sedation, anesthesia, protection of organs to chemical, infectious and cardiovascular damage, and can be administered in a water-based vehicle
07/13/2005EP1551397A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders
07/13/2005CN1638747A Sustained release pharmaceutical composition
07/13/2005CN1636599A Medicine composition and kit for local narcosis or relieving pain
07/07/2005US20050148550 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds
07/06/2005CN1633998A Volatile general anesthetic drug- propofol intravenous intralipid
07/05/2005CA2165446C Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
06/2005
06/29/2005EP0735888B1 Purine compositions
06/22/2005EP1542686A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers
06/22/2005CN1628665A Levobupivacaine freeze dried for injection and preparation method thereof
06/16/2005US20050129754 Halogenated anesthetic in emulsion with lecithin
06/15/2005EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof
06/15/2005EP1539122A2 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
06/15/2005CN1626165A Method for fabricating preparation of del for anesthesia and analgesia on surface of skin
06/15/2005CN1626164A Gel for local anesthesia and analgesia on surface of skin, and usage
06/15/2005CN1626081A Ropivacaine freeze-dried powder and injection preparation in use for injection and preparation method
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/09/2005US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
06/09/2005US20050124668 Amino acids binding to proteins for treatment of pain, tumors, as antidepressants or cognition activators
06/09/2005US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same
06/09/2005US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids
06/09/2005US20050123484 comprising a concentrate of a local anesthetic in a non-alcohol solvent and a hydrofluorocarbon propellant, used for for accurate metered dose delivery
06/08/2005EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005CN1625414A Pharmaceutical composition
06/01/2005CN1622934A Short-acting sedative hypnotic agents for anesthesia and sedation
06/01/2005CN1204020C Terminally sterilized topical patch preparation and production methods thereof
06/01/2005CN1203857C Method for localized anesthesia and analgesia
05/2005
05/26/2005US20050113364 Reacting 3-ethoxy-4-hydroxyphenylacetic acid propyl ester with a compound of the formula X CH2C( .dbd. O)N(CH2CH3)2, wherein X is a leaving group, in the presence of a base to form [4-[(N,N-diethylcarbamoyl)methoxy]-3-ethoxyphenyl]acetic acid propyl ester
05/26/2005US20050112206 Mixture of drug, aminoacrylate polymer and acid
05/25/2005EP0966304B1 Site-specific drug delivery
05/25/2005CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
05/25/2005CN1203061C Substituted isoquinolines, its preparing process, medical composition and its use for preparing medicine
05/17/2005US6894078 Alcohol based topical anesthetic formulation and method
05/12/2005US20050101643 Amino acids with affinity for the alpha2delta-protein
05/12/2005DE10197266T5 Verfahren zur örtlichen Betäubung und Schmerzstillung Method for local anesthesia and pain relief
05/11/2005EP1280531A4 Local anesthetic methods and kits
05/11/2005EP0971898B1 Substituted isoquinolines as ultra short acting neuromuscular blockers
05/10/2005US6890959 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea
05/04/2005EP1527775A1 Controlled release formulation containing tramadol
05/04/2005EP1032368B1 Iontophoretic devices comprising piperidin derivatives
05/03/2005US6887866 Short-acting sedative hypnotic agents for anesthesia and sedation
05/03/2005US6887487 Injectable compositions for the controlled delivery of pharmacologically active compound
04/2005
04/28/2005US20050087198 Method for systemic drug delivery through the nail
04/27/2005EP1526130A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
04/27/2005CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use
04/27/2005CN1198589C Method for controlling liposome size
04/21/2005WO2005009421A3 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity
04/20/2005EP1523307A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means
04/20/2005EP1458355A4 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
04/20/2005EP0954278B1 Pharmaceutical compositions containing kukui nut oil
04/20/2005CN1608064A Novel compounds
04/20/2005CN1607938A Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
04/20/2005CN1607937A Injectable compositions for the controlled delivery of pharmacologically active compound
04/20/2005CN1197550C Composition set and kit for use in intraocular surgery
04/19/2005US6881725 Administering to a subject a purine derivative to reduce traumatic pain, neuropathic pain, organ pain and pain associated with diseases
04/14/2005WO2005032522A1 Topical aerosol foams
04/14/2005WO2005032521A2 Non-flammable topical anesthetic liquid aerosols
04/14/2005WO2005032520A1 Buccal, polar and non-polar spray containing ondansetron
04/14/2005WO2005032517A1 Buccal, polar and non-polar spray containing diazepam
04/14/2005WO2004108061A3 Stable injectable pharmaceutical composition of thiopental; method for stabilizing aqueous solutions of thiopental and, use of thiopental for producing a medicament
04/14/2005CA2582007A1 Buccal, polar and non-polar spray containing diazepam
04/14/2005CA2554954A1 Buccal, polar and non-polar spray containing ondansetron
04/13/2005EP1212052B1 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
04/12/2005US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds
04/07/2005WO2005030700A2 Amino acids with affinity for the alpha2delta-protein
04/07/2005US20050075296 for extending the release times and decreasing the toxicity, by using a di-lauric acid salt of tilmicosin in an acceptable solvent, which forms a precipitate when injected into water; treating infections in dogs and cats where tilmicosin was previously too toxic
04/07/2005CA2540208A1 Amino acids with affinity for the alpha2delta-protein
04/06/2005CN1604900A 6-aminomorphinane derivatives, method for production and use thereof
04/06/2005CN1604800A Drug delivery system for conscious sedation
04/06/2005CN1604779A Novel methods of treating local fungal and bacterial infections
04/06/2005CN1195494C Oral liquid mucoadhesive compositions
04/05/2005US6875777 Compounds
03/2005
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/30/2005EP1518549A1 A pellet comprising a local anesthetic agent and a radiopaque material
03/30/2005EP1517689A2 Selective analgesic agents
03/29/2005US6872733 Benzimidazolone compounds
03/29/2005US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors
03/29/2005US6872390 Local anesthetic methods and kits
03/24/2005US20050065205 Administering protein kinase C activator such as macrocyclic lactone; mixture with enzyme inhibitor and carrier
03/24/2005US20050063943 Conjugated of hydroxyalkyl starch and an active agent
03/23/2005EP1515731A1 Anti-spasmodic comprising xenon
03/22/2005CA2330092C Benzimidazole compounds as orl1-receptor agonists
03/16/2005EP1514539A2 Micro-encapsulated topical analgesic for pain relief and sleeve comprising it
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1513511A1 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/10/2005WO2005009421A8 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity
03/10/2005WO2003007875A9 Compounds with analgesic, antipyretic and/or anti-inflammatory activity
03/09/2005EP1124536B1 Propofol composition comprising pentetate
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 42